Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of NADPH Oxidase in Microvascular Dysfunction Following GDM

NCT05946798 is registered in ClinicalTrials.gov with Anna Stanhewicz, PhD as lead sponsor.

NCT NCT05946798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05946798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of NADPH Oxidase in Microvascular Dysfunction Following GDM
Lead sponsor
Anna Stanhewicz, PhD
Phase
Phase 1
Overall status
Active, not recruiting
Start date
August 30, 2023
Completion date
June 1, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes, oxidative stress, vascular endothelial function